Mazelsky Purchases Shares of DENTSPLY SIRONA

On June 12, 2026, Jonathan Jay Mazelsky purchased 10,000 shares of DENTSPLY SIRONA Inc. (NasdaqGS: XRAY) at an average price of $10.14 each. This transaction was not part of a pre-arranged trading plan and amounted to a total value of $101,400.

Insider Buying and Selling at DENTSPLY SIRONA Inc.

Mazelsky's transaction is part of a series of insider purchases at DENTSPLY SIRONA. Other insiders, including Brian McKeon and Betsy Holden, also acquired shares around the same period. McKeon bought 10,000 shares on June 12 at $10.12 per share, while Holden bought 10,086 shares on June 11 at $9.88 per share.

Other Institutional Activity in DENTSPLY SIRONA

Institutional investors have been actively trading DENTSPLY SIRONA shares. BlackRock, Inc. increased its holdings by 547,312 shares, bringing its total to 19,251,869 shares valued at approximately $223.3 million. First Eagle Investment Management, LLC added 487,378 shares, ending with 15,127,933 shares worth about $175.5 million. Fuller & Thaler Asset Management, Inc. grew its position by 287,008 shares, holding 12,792,518 shares valued at $148.4 million.

DENTSPLY SIRONA Stock Snapshot

Shares of DENTSPLY SIRONA are currently trading around $10.36. The company, with a market cap of $2.03 billion, has a forward P/E ratio of 6.56 and a beta of 0.905. The stock's 52-week range is between $9.41 and $17.09, with a 50-day moving average of $10.98 and a 200-day moving average of $11.98.

Recent Earnings

DENTSPLY SIRONA reported revenue of approximately $3.68 billion, reflecting minimal growth. The company is not currently profitable, with a negative net margin of 17.06% and a return on equity of -37.67%. The next earnings report is anticipated on August 6, 2026.

Dividend

DENTSPLY SIRONA offers an annual dividend rate of $0.64, yielding 5.04% at current prices. The dividend payout ratio stands at 28.83%.

Analysts Set New Price Targets

Analyst opinions on DENTSPLY SIRONA vary. On June 4, 2026, Barclays maintained a 'sell' rating with a $9.00 price target. UBS and Barrington Research both have 'buy' ratings, with targets of $17.00. The consensus rating is 'hold', with a mean target price of $13.40 based on 15 analyst opinions.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc., headquartered in Charlotte, North Carolina, develops and markets dental and healthcare products worldwide. The company operates in four segments, including Connected Technology Solutions and Orthodontic and Implant Solutions. Led by CEO Daniel T. Scavilla, DENTSPLY SIRONA employs about 14,000 people.

Bottom Line

Insider purchases like Mazelsky's are often watched closely by investors, as they can signal confidence in the company's prospects. DENTSPLY SIRONA, a key player in dental equipment and healthcare products, continues to attract institutional interest. Remember, insider transactions are reported after the fact and may not indicate future performance.